Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 263

1.

High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases.

Ohmori S, Shiraki K, Sugimoto K, Sakai T, Fujikawa K, Wagayama H, Takase K, Nakano T.

Hum Pathol. 2001 Dec;32(12):1363-70.

PMID:
11774170
2.

Expression of CD34-positive sinusoidal endothelial cells in patients with HBV-associated chronic liver diseases.

Ohmori S, Shiraki K, Sugimoto K, Yamanaka Y, Yamaguchi Y, Saitou Y, Fujikawa K, Murata K, Nakano T.

Int J Mol Med. 2004 Aug;14(2):179-84.

PMID:
15254762
3.

Enhanced CD34 expression of sinusoid-like vascular endothelial cells in hepatocellular carcinoma.

Cui S, Hano H, Sakata A, Harada T, Liu T, Takai S, Ushigome S.

Pathol Int. 1996 Oct;46(10):751-6.

PMID:
8916144
4.

Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma.

An FQ, Matsuda M, Fujii H, Matsumoto Y.

J Cancer Res Clin Oncol. 2000 Mar;126(3):153-60.

PMID:
10741909
6.

High expression of p21WAF1/CIP1 is correlated with human hepatocellular carcinoma in patients with hepatitis C virus-associated chronic liver diseases.

Wagayama H, Shiraki K, Sugimoto K, Ito T, Fujikawa K, Yamanaka T, Takase K, Nakano T.

Hum Pathol. 2002 Apr;33(4):429-34.

PMID:
12055678
7.

Inducible nitric oxide synthase expression is related to angiogenesis, bcl-2 and cell proliferation in hepatocellular carcinoma.

Peng JP, Zheng S, Xiao ZX, Zhang SZ.

J Zhejiang Univ Sci. 2003 Mar-Apr;4(2):221-7.

PMID:
12659238
8.
10.

Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma.

Yamamoto A, Dhar DK, El-Assal ON, Igarashi M, Tabara H, Nagasue N.

J Hepatol. 1998 Aug;29(2):290-9.

PMID:
9722211
11.
12.

Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma.

Poon RT, Lau CP, Ho JW, Yu WC, Fan ST, Wong J.

Clin Cancer Res. 2003 Nov 1;9(14):5339-45.

13.

8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.

Chuma M, Hige S, Nakanishi M, Ogawa K, Natsuizaka M, Yamamoto Y, Asaka M.

J Gastroenterol Hepatol. 2008 Sep;23(9):1431-6. doi: 10.1111/j.1440-1746.2008.05502.x.

PMID:
18854000
14.

Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C.

Dutta U, Kench J, Byth K, Khan MH, Lin R, Liddle C, Farrell GC.

Hum Pathol. 1998 Nov;29(11):1279-84.

PMID:
9824107
15.

The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.

Nada O, Abdel-Hamid M, Ismail A, El Shabrawy L, Sidhom KF, El Badawy NM, Ghazal FA, El Daly M, El Kafrawy S, Esmat G, Loffredo CA.

J Clin Virol. 2005 Oct;34(2):140-6.

PMID:
16157266
16.
17.

Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.

Yao DF, Wu XH, Zhu Y, Shi GS, Dong ZZ, Yao DB, Wu W, Qiu LW, Meng XY.

Hepatobiliary Pancreat Dis Int. 2005 May;4(2):220-6.

18.

Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus.

Zhou J, Tang ZY, Fan J, Wu ZQ, Li XM, Liu YK, Liu F, Sun HC, Ye SL.

J Cancer Res Clin Oncol. 2000 Jan;126(1):57-61.

PMID:
10641751
19.

Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma.

Torimura T, Sata M, Ueno T, Kin M, Tsuji R, Suzaku K, Hashimoto O, Sugawara H, Tanikawa K.

Hum Pathol. 1998 Sep;29(9):986-91.

PMID:
9744316
20.

Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance.

Tanigawa N, Lu C, Mitsui T, Miura S.

Hepatology. 1997 Nov;26(5):1216-23.

PMID:
9362365

Supplemental Content

Support Center